Finance

Lists
GYRE:NASDAQ
Gyre Therapeutics Inc
5,81 US$
+3,01%
(+0,17) 1D
5,81 US$
0,00% (0,00)
After hours
Closed: 30 ივლ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Open
5,72 US$
High
5,95 US$
Low
5,72 US$
Mkt. cap
530,87 მლნ.
Avg. vol.
96,89 ათ.
Volume
45,64 ათ.
52-wk high
9,42 US$
52-wk low
5,44 US$
EPS
-0,07 US$
Beta
2,18
Shares outstanding
111,49 მლნ.
No. of employees
625
Open
5,72 US$
High
5,95 US$
Low
5,72 US$
Mkt. cap
530,87 მლნ.
Avg. vol.
96,89 ათ.
Volume
45,64 ათ.
52-wk high
9,42 US$
52-wk low
5,44 US$
EPS
-0,07 US$
Beta
2,18
Shares outstanding
111,49 მლნ.
No. of employees
625
News stories
From sources across the web
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
Headquartersუინსტონ-სალემი, ჩრდილოეთი კაროლინა, ამერიკის შეერთებული შტატები
Sector-
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current 5,81 US$
20,00 US$ (+244,23%)
Average
19,00 US$ (+227,02%)
Lowest
18,00 US$ (+209,81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
20,00 US$
+244,2%
05/08/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
18,00 US$
+209,8%
05/07/2026
Roger Song
Jefferies
Buy
Initiated
16,00 US$
+175,4%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
26,77 მლნ.
30,56 მლნ.
37,20 მლნ.
22,52 მლნ.
Cost of goods sold
1,15 მლნ.
1,63 მლნ.
1,74 მლნ.
1,23 მლნ.
Cost of revenue
1,15 მლნ.
1,63 მლნ.
1,74 მლნ.
1,23 მლნ.
Research and development expenses
3,42 მლნ.
2,36 მლნ.
4,82 მლნ.
6,74 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,02 მლნ.
19,65 მლნ.
30,52 მლნ.
21,36 მლნ.
Operating expense
23,45 მლნ.
22,01 მლნ.
35,33 მლნ.
28,09 მლნ.
Total operating expenses
24,60 მლნ.
23,64 მლნ.
37,08 მლნ.
29,32 მლნ.
Operating income
2,17 მლნ.
6,93 მლნ.
120,00 ათ.
-6,80 მლნ.
Other non operating income
-133,00 ათ.
604,00 ათ.
-2,31 მლნ.
118,00 ათ.
EBT including unusual items
2,24 მლნ.
7,63 მლნ.
-66,00 ათ.
-9,24 მლნ.
EBT excluding unusual items
2,24 მლნ.
7,63 მლნ.
-864,00 ათ.
-6,68 მლნ.
Income tax expense
662,00 ათ.
1,69 მლნ.
1,30 მლნ.
621,00 ათ.
Effective tax rate
29,58%
22,19%
-1 969,70%
-6,72%
Other operating expenses
-
-
-
-
Net income
442,00 ათ.
3,61 მლნ.
-1,72 მლნ.
-8,69 მლნ.
Net profit margin
1,65%
11,81%
-4,63%
-38,59%
Earnings per share
-
0,03
0,05
-
Interest and investment income
200,00 ათ.
100,00 ათ.
1,35 მლნ.
-
Interest expense
-
-
-
-
Net interest expenses
200,00 ათ.
100,00 ათ.
1,35 მლნ.
-
Depreciation and amortization charges
-
-
-
-
EBITDA
2,81 მლნ.
7,58 მლნ.
815,00 ათ.
-6,13 მლნ.
Gain or loss from assets sale
1,00 ათ.
1,00 ათ.
2,00 ათ.
16,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები